Volume 67 Received 18 October 2010 | ||||||||||
| ||||||||||
aSchool of Pharmaceutical Sciences, Nanjing University of Technology, No. 5 Xinmofan Road, Nanjing 210009, People's Republic of China,bJiangsu Provincial Institute of Materia Medica, Nanjing University of Technology, No. 26 Majia Street, Nanjing 210009, People's Republic of China, and cPRC DAYAOWAN Administration for Entry & Exit Inspection and Quarantine, Haiqingdao Foreign Area Development Zone, Dalian 116610, Liaoning Province, People's Republic of China
Correspondence e-mail: jiajing.jj@gmail.com
In the molecule of the title compound, C14H10FN3O, the bicyclic quinazoline system is effectively planar, with a mean deviation from planarity of 0.0140 (3) Å. The quinazoline heterocyclic system and the adjacent benzene ring make a dihedral angle of 85.73 (9)°. Two intermolecular N-H
N hydrogen bonds contribute to the stability of the crystal structure. In addition, a weak
-
stacking interaction [centroid-centroid distance = 3.902 (2) Å] is observed.
For general background to quinazolines, see: Labuda et al. (2009
). Graves et al. (2002
); For the preparation of the title compound, see: Zhang et al. (2010
). For bond-length data, see: Allen et al. (1987
).
|
|
| ||||||||||||||||||||||
Data collection: CAD-4 EXPRESS (Enraf-Nonius, 1994
); cell refinement: CAD-4 EXPRESS; data reduction: XCAD4 (Harms & Wocadlo, 1995
); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: SHELXTL (Sheldrick, 2008
); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: ZL2317 ).
The authors thank the Center of Testing and Analysis, Nanjing University, for the data collection.
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Enraf-Nonius (1994). CAD-4 EXPRESS. Enraf-Nonius, Delft, The Netherlands.
Graves, P. R., Kwiek, J. J., Fadden, P., Ray, R., Hardeman, K., Coley, A. M., Foley, M. & Haystead, T. A. J. (2002). Mol. Pharmacol. 62, 1364-1372.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Harms, K. & Wocadlo, S. (1995). XCAD4. University of Marburg, Germany.
Labuda, J., Ovadekova, R. & Galandova, J. (2009). Mikrochim. Acta, 164, 371-377.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
North, A. C. T., Phillips, D. C. & Mathews, F. S. (1968). Acta Cryst. A24, 351-359.
![[details]](../../../../../../a/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Zhang, A. H., Yuan, S. T., Shen, Y. P., Wu, Y. D. & Ji, A. C. (2010). CN Patent Appl. CN101671301.